Group One Trading’s ProPhase Labs PRPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-170
| Closed | -$778 | – | 8946 |
|
|
2025
Q3 | $778 | Hold |
170
| – | – | ﹤0.01% | 8095 |
|
|
2025
Q2 | $665 | Hold |
170
| – | – | ﹤0.01% | 7626 |
|
|
2025
Q1 | $687 | Buy |
+170
| New | +$780 | ﹤0.01% | 7237 |
|
|
2024
Q3 | – | Sell |
-80
| Closed | -$3.34K | – | 7217 |
|
|
2024
Q2 | $3.34K | Buy |
80
+30
| +60% | +$1.57K | ﹤0.01% | 6105 |
|
|
2024
Q1 | $3.23K | Sell |
50
-30
| -38% | -$1.52K | ﹤0.01% | 6348 |
|
|
2023
Q4 | $3.62K | Buy |
+80
| New | +$3.65K | ﹤0.01% | 6632 |
|
|
2023
Q3 | – | Sell |
-50
| Closed | -$3.63K | – | 8146 |
|
|
2023
Q2 | $3.63K | Sell |
50
-50
| -50% | -$4.07K | ﹤0.01% | 6854 |
|
|
2023
Q1 | $7.62K | Buy |
+100
| New | +$8.06K | ﹤0.01% | 6088 |
|
|
2022
Q4 | – | Sell |
-300
| Closed | -$34K | – | 7916 |
|
|
2022
Q3 | $34K | Buy |
+300
| New | +$34.9K | ﹤0.01% | 5715 |
|
|
2022
Q1 | – | Sell |
-40
| Closed | -$3K | – | 8540 |
|
|
2021
Q4 | $3K | Sell |
40
-490
| -92% | -$30.5K | ﹤0.01% | 7805 |
|
|
2021
Q3 | $28K | Sell |
530
-1,160
| -69% | -$69.1K | ﹤0.01% | 6967 |
|
|
2021
Q2 | $105K | Buy |
+1,690
| New | +$94.9K | ﹤0.01% | 5901 |
|
Other funds holding PRPH
Group One Trading's PRPH Position: Q3 2024 in Review
Group One Trading sold out of ProPhase Labs (PRPH) in Q3 2024, closing a stake of 71 shares — an estimated $2.95K sold.
Group One Trading first reported a position in PRPH in Q4 2021 and held it in 5 quarters. The position peaked at $35K in Q1 2022. 27 funds tracked by Wall St. Rank hold PRPH as of Q3 2024.
- Group One Trading reported no remaining ProPhase Labs position as of Q3 2024 after selling out during the quarter.
- Group One Trading sold 71 ProPhase Labs shares in Q3 2024, an estimated $2.95K.
- Group One Trading first reported a position in ProPhase Labs in Q4 2021 and held it in 5 quarters.
- Group One Trading's ProPhase Labs position peaked at $35K in Q1 2022.
- 27 funds tracked by Wall St. Rank held ProPhase Labs as of Q3 2024.
Based on Group One Trading's 13F filing for Q3 2024, filed 14 Nov 2024.